Barely Significant
← all excerpts

Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis.

Med Sci Monit · 2015 · PMC4386591 · PMID 25811545

Europe PMCDOI
1
hedged sentence
0.0002
closest p · 0.0× alpha
0.0002
boldest claim

The sentences

quite significantP=0.0002actually significant
Similar to mid-term mortality, subgroup analysis showed that LVEF improvement was quite significant in levosimendan vs. placebo subgroups (mean difference: 5.65%, 95%CI: 2.72–8.57%, P=0.0002, I 2 =33%) ( Figure 4 ).

also in 3,924 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.